{"url_path":"/sec/juns/10-q/2026/item-6","section_key":"item-6","section_title":"Item 6 EXHIBITS","topic":"sec","document":{"doc_type":"10-Q","doc_date":"2026-05-14","source_url":"https://www.sec.gov/Archives/edgar/data/1679628/0001493152-26-023164-index.html","accession_number":"0001493152-26-023164","cik":"0001679628","ticker":"JUNS","issuer_name":"JUPITER NEUROSCIENCES, INC.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1679628/0001493152-26-023164-index.html","primary_entity_key":"0001679628","primary_entity_name":"JUPITER NEUROSCIENCES, INC."},"word_count":241,"has_tables":true,"body_markdown":"ITEM\n6. EXHIBITS\n\n \n\n**Exhibit\nNo.**\n \n**Descriptio**n\n\n4.1\n \n[Omnibus Amendment to the Convertible Promissory Notes issued to YA II PN, Ltd., dated February 20, 2026, between Jupiter Neurosciences, Inc. and YA II PN, Ltd. (incorporated by reference to Exhibit 4.3 to the Registrant’s Current Report on Form 8-K filed with the SEC on February 27, 2026)](https://www.sec.gov/Archives/edgar/data/1679628/000149315226007624/ex4-3.htm)\n\n31.1*\n \n[Certification of Principal Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act*](ex31-1.htm)\n\n31.2*\n \n[Certification of Principal Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act*](ex31-2.htm)\n\n32.1*\n \n[Certification of Principal Executive Officer Pursuant to Section 906 of the Sarbanes-Oxley Act**](ex32-1.htm)\n\n32.2*\n \n[Certification of Principal Financial Officer Pursuant to Section 906 of the Sarbanes-Oxley Act**](ex32-2.htm)\n\n101.INS*\n \nInline\nXBRL Instance Document*\n\n101.SCH*\n \nInline\nXBRL Taxonomy Extension Schema Document*\n\n101.CAL*\n \nInline\nXBRL Taxonomy Extension Calculation Linkbase Document*\n\n101.DEF*\n \nInline\nXBRL Taxonomy Extension Definition Linkbase Document*\n\n101.LAB*\n \nInline\nXBRL Taxonomy Extension Label Linkbase Document*\n\n101.PRE*\n \nInline\nXBRL Taxonomy Extension Presentation Linkbase Document*\n\n104*\n \nCover\nPage Interactive Data File (embedded within the Inline XBRL document)*\n\n \n\n*\nFiled herewith.\n\n \n\n**\nFurnished herewith.\n\n \n\n27\n\n \n\n \n\nSIGNATURES\n\n \n\nPursuant\nto the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by\nthe undersigned thereunto duly authorized.\n\n \n\n \n**Jupiter\nNeurosciences, Inc.**\n\n \n \n\nDate:\nMay 14, 2026\n*/s/\nChrister Rosén*\n\n \nChrister\nRosén\n\n \nChief\nExecutive Officer\n\n \n(Principal\nExecutive Officer)\n\n \n \n\nDate:\nMay 14, 2026\n*/s/\nSaleem Elmasri*\n\n \nSaleem\nElmasri\n\n \nChief\nFinancial Officer\n\n \n(Principal\nFinancial Officer and Principal Accounting Officer)\n\n \n\n28"}